FDA OKs new therapy for some hemophilia sufferers

Linda A. Johnson, Ap medical creator

up to date 10:33 am, Thursday, November 16, 2017 This picture supplied by using Genentech, Inc. indicates a kit of the drug Hemlibra. On Thursday, Nov. sixteen, 2017, the meals and Drug Administration permitted Hemlibra, the first new remedy in well-nigh two many years to stay away from inside bleeding in certain sufferers with hemophilia, an inherited blood-clotting disease. (Genentech, Inc. by means of AP) less This photograph offered by using Genentech, Inc. indicates a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the food and Drug Administration permitted Hemlibra, the primary new remedy in very nearly two a long time to ... extra image: AP

FDA OKs new therapy for some hemophilia sufferers

TRENTON, N.J. (AP) — U.S. regulators have authorized the primary new treatment in just about two a long time to steer clear of inner bleeding in certain patients with hemophilia, an inherited blood-clotting sickness.

The meals and Drug Administration on Thursday permitted Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A sufferers who have developed resistance to usual medicines.

Genentech, the drug's developer, says the list rate could be about $482,000 for the first 12 months and a bit much less after that.

Genentech, a subsidiary of Swiss drugmaker Roche, says this is half the can charge of the most effective other choice for sufferers with this resistance. That remedy requires an IV drip several times a week.

Hemophilia typically affects men.